In an AD mouse model, administration of anti-IL-17A antibody to block IL-17A generation could decrease the neuroinflammation induced by Aβ-42 injection, reduced neuronal neurodegeneration, and improve the cognitive impairment of the mice [66]. The gene discussed is IL17A; the disease is Alzheimer disease.